The Albanese Government has released its 2023-24 Mid-Year Economic Fiscal Outlook, which includes $3.5 billion since the May Budget for new medicines on the PBS, but also an expected decline in spending on the program that must be qualified because the estimate does not include the impact of future new listings.
Update reveals significant spending on new listings since the May Budget
December 13, 2023 Latest NewsBioPharma
Latest Video
New Stories
-
Australian company secures European approval for rare disease treatment
August 26, 2026 - - Latest News -
Australia cannot deliver meaningful change until the levers of power are rebalanced
August 26, 2026 - - Latest News -
Insurers warn cut could hit Australians most likely to need cancer care
August 25, 2026 - - Latest News -
Australian study finds maternal RSV vaccination offers strong protection for infants
August 25, 2026 - - Latest News -
Acrux brings experienced clinical leader aboard to advance testosterone program
August 24, 2026 - - Australian Biotech -
Avecho moves to deepen global partnering push as CBD insomnia program advances
August 24, 2026 - - Australian Biotech -
July recommendations across oncology, rare disease and chronic care
August 24, 2026 - - Latest News

